Morphic (MORF)
搜索文档
Morphic (MORF) - 2022 Q4 - Annual Report
2023-02-23 22:14
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13, OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38940 MORPHIC HOLDING, INC. (Exact name of registrant as specified in its charter) Delaware 47-3878772 (State or ...
Morphic Holding (MORF) Investor Presentation - Slideshow
2022-03-26 02:00
DELIVERING A NEW GENERATION OF INTEGRIN MEDICINES March 2022 Forward Looking Statements This presentation contains "forward-looking" statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to: Morphic's or our partners' plans to develop and commercialize oral small-molecule integrin therapeutics and Morphic's expectations about timing and ability to commence, enroll or complete clinical studies and to obtain regulatory ...
Morphic Holding (MORF) Investor Presentation - Slideshow
2021-09-11 02:14
DELIVERING A NEW GENERATION OF INTEGRIN MEDICINES September 2021 Forward Looking Statements This presentation contains "forward-looking" statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to: Morphic's or our partners' plans to develop and commercialize oral small-molecule integrin therapeutics and Morphic's expectations about timing and ability to commence, enroll or complete clinical studies and to obtain regula ...
Morphic (MORF) - 2020 Q4 - Earnings Call Transcript
2021-03-02 03:28
Morphic Holding, Inc. (NASDAQ:MORF) Q4 2020 Earnings Conference Call March 1, 2021 8:00 AM ET Company Participants Chris Erdman - Senior Vice President of Communications Praveen Tipirneni - Chief Executive Officer Marc Schegerin - Chief Operating Officer and Chief Financial Officer Bruce Rogers - Chief Scientific Officer Peter Linde - Chief Medical Officer Conference Call Participants Michael Yee - Jefferies Gregory Renza - RBC Capital Markets Do Kim - BMO Capital Markets Ritu Baral - Cowen Yasmeen Rahimi - ...